EMMAUS LIFE SCIENCES, INC. Common Stock Purchase WarrantCommon Stock Purchase Warrant • March 7th, 2023 • Emmaus Life Sciences, Inc. • Pharmaceutical preparations
THIS CERTIFIES THAT, for value received, Crystal Research Associates, LLC, a limited liability company, or registered assigns (the “Holder”), is entitled to subscribe for and purchase, at the Exercise Price (as defined below), from Emmaus Life Sciences, Inc., a Delaware corporation (the “Company”), shares of the Company’s common stock, par value $0.001 (the “Common Stock”), at any time from January 27, 2023 and prior to 5:00 p.m., New York time, on January 26 2028 (the “Warrant Exercise Term”).
